Shantipriya Siripurapu, MD
Internal Medicine · Phoenix, AZNPI 1740202860
Payments from drug & device makers
Across 338 payments — averaging $29.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- AbbVie$914
- Lilly USA, LLC$855
- GSK$767
- Boehringer Ingelheim$536
- plus $3K from 32 others
What the payments were for
- Food & beverage$9,989100%
- Education$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $2,105 |
| AstraZeneca | 39 | $1,433 |
| AbbVie(2 entities) | 58 | $914 |
| Lilly USA, LLC | 48 | $855 |
| GSK | 10 | $767 |
| Boehringer Ingelheim | 22 | $536 |
| Amgen | 11 | $485 |
| Pfizer | 13 | $417 |
| Dexcom, Inc. | 10 | $345 |
| Amarin Pharma, Inc. | 5 | $194 |
| Stryker | 1 | $171 |
| W. L. Gore & Associates, Inc. | 1 | $152 |
| Corcept Therapeutics | 4 | $145 |
| Abiomed | 2 | $143 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $143 |
| Bayer | 4 | $140 |
| Boston Scientific | 2 | $125 |
| United Therapeutics Corporation | 1 | $121 |
| Johnson & Johnson | 4 | $117 |
| Abbott | 5 | $112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $84 |
| Biohaven Pharmaceuticals, Inc. | 2 | $71 |
| Philips North America LLC | 3 | $54 |
| Exact Sciences | 3 | $53 |
| Merck | 3 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Novartis | 2 | $31 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $23 |
| Insulet Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Analog Devices Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Gilead | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$712
- BREZTRI$492
- Wegovy$467
- TRELEGY ELLIPTA$452
- Repatha$241
- FlowTriever$171
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$152
- VRAYLAR$132
- Vascepa$127
- ELIQUIS$125
- SHINGRIX$125
- AIRSUPRA$125
- Korlym$125
- KISUNLA$121
- KRYSTEXXA$121
- ORENITRAM$121
- NURTEC ODT$119
- DEXCOM G6 TRANSMITTER$119
- FARXIGA$107
- DEXCOM G7 GSS (161)$104
How this compares
$10,016 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Phoenix
- Louise TaberPhoenix$8.5M
- Ernie RifferPhoenix$3M
- Frank LovecchioPhoenix$945K
- Allison PerrinPhoenix$861K
- Nasser HajaigPhoenix$687K
- Richard TayrienPhoenix$299K
- Sanjay ShahPhoenix$288K
- Kelly KrohnPhoenix$262K
- Paul WaxPhoenix$243K
- Paul StanderPhoenix$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.